NASDAQ:HRMY

Harmony Biosciences Holdings Stock News

etoro logo Buy HRMY
*Your capital is at risk
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. The post 7 No-Brainer Biotech Stocks to Add to Your Buy List appeared first
Harmony has done very well monetizing their first asset. They have to start planning for the future.
HRMY earnings call for the period ending March 31, 2022.

Harmony Biosciences Holdings, Inc. (HRMY) Beats Q1 Earnings Estimates

12:55pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 104% and 2.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for t
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Luis Sanay - Head, IR John C. Jacobs - President and CEO Jeffrey Dierks -
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 104% and 2.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for t
Upgrades For United Parcel Service Inc (NYSE:UPS), Loop Capital upgraded the previous rating of Hold to Buy. For the fourth quarter, United Parcel Service had an EPS of $3.59, compared to year-ago qua
Where is the market going after last week's rally? Our call of the day from MKM's chief strategist is looking at healthy signals from the healthcare sector.
PLYMOUTH MEETING, Pa., March 9, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializin

Harmony Biosciences: Strong Growth At A Reasonable Price

06:19am, Friday, 04'th Mar 2022 Seeking Alpha
HRMY earnings call for the period ending December 31, 2021.
HRMY earnings call for the period ending December 31, 2021.

Harmony Biosciences: Q4 Earnings Insights

03:44pm, Monday, 28'th Feb 2022 Benzinga
Harmony Biosciences (NASDAQ: HRMY ) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM. Here''s what investors need to know about the announcement. Earnings Harmony Biosciences beat estimated earnings by 70.27%, reporting an EPS of $0.63 versus … Full story available on Benzinga.com
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE